APOTEX INC.

In News

Apotex announces leadership changes - prnewswire.com

prnewswire.com - Mar 30, 2026

Generic drugmaker Apotex switches CEO ahead of planned IPO - The Globe and Mail

The Globe and Mail - Mar 30, 2026

Apotex announces Jeff Watson as new CEO after Allan Oberman steps down - Castanet

Castanet - Mar 30, 2026

Apotex announces Jeff Watson as new CEO after Allan Oberman steps down - barchart.com

barchart.com - Mar 30, 2026

Apotex announces Jeff Watson as new CEO after Allan Oberman steps down - thestar.com

thestar.com - Mar 30, 2026

Apotex announces Jeff Watson as new CEO after Allan Oberman steps down - The Spec

The Spec - Mar 30, 2026

Apotex Expands Canadian Ophthalmology Portfolio with Health Canada's Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%) - prnewswire.com

prnewswire.com - Mar 25, 2026

Canadian Drugmaker Apotex Seeks Up to $730 Million in First-Half IPO - Bloomberg.com

Bloomberg.com - Feb 23, 2026

Generic drug giant targets up to $1 billion TSX float - Benefits and Pensions Monitor

Benefits and Pensions Monitor - Feb 25, 2026

Axsome Sues Apotex to Block Copies of Symbravo Migraine Drug - Bloomberg Law News

Bloomberg Law News - Sep 29, 2025

Apotex plans $1-billion initial public offering - The Globe and Mail

The Globe and Mail - Feb 24, 2026

Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer - prnewswire.com

prnewswire.com - Oct 23, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment